Keratin 17 (KRT17) Peptide
KRT17
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN939286
Aperçu rapide pour Keratin 17 (KRT17) Peptide (ABIN939286)
Antigène
KRT17
(Keratin 17 (KRT17))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Type de proteíne
- Synthetic
-
Séquence
- IATYRRLLEG EDAHLTQYKK EPVTTRQVRT IVEEVQDGKV ISSREQVHQT
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KRT17 antibody,
Alternative Names: Cytokeratin 17 control peptide, Cytokeratin 17 antibody Blocking Peptide, Anti-Cytokeratin 17 Blocking Peptide, Keratin 17 Blocking Peptide, K17 Blocking Peptide, PC Blocking Peptide, PC2 Blocking Peptide, PCHC1 Blocking Peptide, KRT17 Blocking Peptide, Cytokeratin 17, Cytokeratin -17, Cytokeratin 17, Cytokeratin -17 Blocking Peptide, Cytokeratin 17 Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- KRT17 (Keratin 17 (KRT17))
-
Sujet
- KRT17 is type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in its gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.KRT17 encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.
-
Poids moléculaire
- 48 kDa
Antigène
-
Vous êtes ici:
